The Medical Letter Online

Tag: human

BRONCHIAL COUGH THERAPY (Antimony Potassium Tartrate – Protortonia Cacti – Drosera Rotundifolia – Echinacea, Unspecified – Calcium Sulfide – Human Sputum, Bordetella Pertussis Infected – Spongia Officinalis Skeleton, Roasted -) Tablet, Orally Disintegrating [TRP Company]

| October 29, 2012 | 0 Comments

Updated Date: Oct 22, 2012 EST DailyMed Drug Label Updates for the last seven days (since Oct 22, 2012 EST)

Continue Reading

Human medicines European Public Assessment Report (EPAR): Protopic, tacrolimus, Revision: 15, Authorised

| October 26, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Cialis, tadalafil, Revision: 14, Authorised

| October 23, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Flebogamma DIF (previously Flebogammadif), human normal immunoglobulin, Revision: 7, Authorised

| October 21, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Riprazo HCT , aliskiren / hydrochlorothiazide, Revision: 0, Withdrawn

| October 20, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Eklira Genuair, aclidinium bromide, Revision: 0, Authorised

| October 19, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

News and press releases: Dr Tomas Salmonson elected new chair of the Committee for Medicinal Products for Human Use (CHMP)

| October 15, 2012 | 0 Comments

The Committee for Medicinal Products for Human Use (CHMP) has elected Tomas Salmonson as its new chair for a three-year mandate. Patient safety, news and press releases: human and vet

Continue Reading

Human medicines European Public Assessment Report (EPAR): Inlyta, axitinib, Revision: 0, Authorised

| October 13, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Foreign Review Attestation and Summary of Quality Differences: Subsequent Market Entry Products (Human Drugs) Form.

| September 30, 2012 | 0 Comments

Health Canada RSS – Drug Products, Drugs and Health Products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Instanyl, fentanyl, Revision: 6, Authorised

| September 30, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Next Page »